Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Measurement of Lipogenic Flux by Deuterium Resolved Mass Spectrometry Via Non-invasive Breath Analysis

NCT05274334 is registered in ClinicalTrials.gov with University Children's Hospital Basel as lead sponsor.

NCT NCT05274334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05274334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Measurement of Lipogenic Flux by Deuterium Resolved Mass Spectrometry Via Non-invasive Breath Analysis
Lead sponsor
University Children's Hospital Basel
Phase
Not applicable
Overall status
Completed
Start date
May 11, 2022
Completion date
September 30, 2022
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

de novo lipogenesis (dnl)